Personalisation is the future of cancer care
Unique journey
Related Posts
Migraine takes the spotlight at European Parliament
EMHA calls for its inclusion in EU neurological health strategy The European Migraine and Headache Alliance (EMHA) has urged EU policymakers to include migraine in […]
International KCL research project to develop SMARTdrugs for aggressive cancers
The platform will be used to diagnose and treat cancers, including lung and brain tumours A new international study led by King’s College London (KCL) […]
Positive results for MAIA’s SCLC treatment published in Nature Communications
The aggressive type of cancer accounts for 13% of all lung cancer cases worldwide MAIA Biotechnology has announced that positive results from its preclinical studies […]